Compounding pharmacies make customized medicines for individual patients, and under section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can compound from a bulk substance only if that substance has an official quality monograph, is a component of an FDA-approved drug, or has been formally added to an approved bulks list. BPC-157 qualifies on none of those counts, which is why the FDA placed it in Category 2 of its 503A bulk-substance review in September of 2023
Some studies have shown that facial cream provides its own mix of benefits
For example, one study found that after taking 1,000 mcg of oral vitamin B12, only about 1.3% (13 mcg) is absorbed into the bloodstream
Unlike many bioactive peptides, BPC-157 contains no cysteine residues and forms no disulfide bridges
A mistake here could have catastrophic consequences
sub-gram doses may support general antioxidant health but produce minimal visible skin change